SOURCE: PHT Corporation

April 21, 2008 03:00 ET

PHT Corporation's 5th Annual European User Group Meeting to Convene ePRO Industry Pacesetters

Customer Case Studies, Expert Presentations, and Informal Discussions Highlight Europe's Only Annual ePRO User Group Meeting

BOSTON, MA--(Marketwire - April 21, 2008) - PHT Corporation, the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 345 clinical trials worldwide, will gather industry trendsetters at its 5th Annual European User Group Meeting, on 20-22 May, in France to discuss important topics in global eClinical research.

PHT's European User Group Meeting is exclusive to PHT customers and partners. It is the only meeting of its kind in Europe and over the past four years has become a highlight for both experienced and novice ePRO users from top pharmaceutical, biotechnology and medical device companies.

This year the conference offers a range of sessions and topics, including:

--  ePRO orientation and basics, and global ePRO implementation
--  Optimizing the UST process
--  New and planned PHT product updates
--  Demonstrations of the revolutionary SitePad™ Tablet
--  ePRO for fraud detection
--  Customer case studies on ePRO validation
--  Defining types of eClinical data integrations
    

Interactive Breakout Sessions offer participants an opportunity to discuss relevant eClinical industry issues with subject matter experts, while dedicated "You Tell Us" sessions allow participants to share feedback and ideas for new products and service enhancements.

PHT executives attending the conference will include Phil Lee, President and CEO; Stephen Raymond, Ph.D., Founder and Chief Scientific and Quality Officer; Linda Beneze, Vice President of Sales and Client Services; Sheila Rocchio, Vice President of Marketing; Ian McLeod, Vice President of Development; Jodi Holman, Director of Client Operations; and, Dwight Cooper, Global Director, Technical Services.

"The 5th Annual European User Group Meeting is an important event in the expansion of ePRO solutions for larger, more complex trials worldwide," said Phil Lee, President and CEO of PHT. "We look forward to sharing experiences, ideas and issues with our growing European clients and partners."

Clinical research representatives from past and present PHT clients can see more details and register online at http://www.phtcorp.com/EuroUGM/.

About PHT Corporation

Trust your patient and questionnaire data again. PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 345 clinical trials by 90 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad™ Tablet deliver the voice of the patient, in 80 languages, from homes and sites in 60 countries around the world. By capturing high-quality and timestamped assessments with minimal respondent burden, transmitted over reliable analog and wireless global technologies, sponsors are able to run smaller and more conclusive clinical research programs. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry's premier study archive. Patient experiences captured firsthand by PHT's ePRO Product Suite have been used successfully in at least 11 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com

PHT, LogPad and SitePad are among the registered trademarks and trademarks of PHT Corporation.

Contact Information